thyroid cancer Jul 29, 2021 Veracyte Q2 Revenues More Than Double on Test Volume Spike Dec 22, 2020 Bayer, Veracyte to Identify Therapy-Resistant Thyroid Cancer Patients Dec 10, 2020 Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer Nov 3, 2020 Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Jun 9, 2020 NeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing Program Apr 21, 2020 ArcherDx, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers Jan 31, 2020 Chilean Startup GeneproDx Developing Molecular Test to Determine Thyroid Cancer Risk Premium Dec 20, 2019 Interpace Biosciences Expanding Beyond Dx, Cancer With Acquisition, Name Change Premium Dec 19, 2019 Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors Dec 2, 2019 NantHealth, Qiagen Shares Increase Sharply, Myriad Declines as 360Dx Index Rises 5 Percent in November Dec 2, 2019 Genetron Health Gets China NMPA Approval for Clinical NGS System, Files for IPO Nov 13, 2019 Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences Nov 5, 2019 Sonic Healthcare Expands Deal for UPMC's ThyroSeq Thyroid Cancer Test Oct 16, 2019 UT, Baylor Researchers Develop Mass Spec Test for Thyroid Cancer Premium Sep 30, 2019 Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans Sep 9, 2019 Thermo Fisher Scientific, Eli Lilly to Develop CDx for RET Inhibitor Aug 13, 2019 Interpace Diagnostics Q2 Revenues Climb 14 Percent Jul 31, 2019 Interpace Diagnostics Thyroid Tests Covered In-Network by BCBS of Michigan Jul 29, 2019 Interpace Diagnostics Thyroid Assays Covered In-Network by Blue Shield of California Jul 22, 2019 Interpace Diagnostics, SelectHealth Sign Coverage Agreement for Thyroid Cancer Tests Load More Breaking News Roche Alzheimer's Disease Assays Obtain FDA 510(k) Clearance Diazyme Gets FDA Emergency Use Authorization for SARS-CoV-2 Antibody Test HHS Report Identifies Labs Billing for Unusually High Amounts of COVID-19 Add-on Testing FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy DiaSorin, PerkinElmer, Roche, Others Nab FDA 510(k) Clearances in November Mainz Biomed to Initiate Pivotal US Clinical Study for Colorectal Cancer Early Detection Test
